Saudi Press

Saudi Arabia and the world
Friday, Nov 28, 2025

Facebook paid ads are promoting a horse drug as a COVID cure

Facebook paid ads are promoting a horse drug as a COVID cure

Paid adverts, Marketplace listings and closed groups are promoting a discredited drug. The experts say it's not a cure, and people shouldn't use it to treat the virus.

A drug commonly used to treat parasites in horses, cattle, and dogs is being promoted as a COVID-19 cure in Facebook groups and paid adverts hosted on the company's platforms, Euronews Next has found.

Information from Facebook's open "Ad Library" shows the company is currently showing users paid adverts that promote Ivermectin as a treatment for COVID-19. While Ivermectin is used to treat some conditions in humans, the drug is not licensed or approved for use in treating COVID-19.

Euronews Next also found evidence of closed Facebook groups that offer advice on sourcing and using Ivermectin, as well as examples of it being offered for sale on Facebook Marketplace and within Facebook groups.

Many of the active adverts on Facebook were purchased this week, days after public health officials in the US state of Mississippi announced that "at least 70 per cent" of recent calls to poison control helplines in the state were "related to ingestion of livestock or animal formulations of Ivermectin purchased at livestock supply centres".

Facebook's disinformation marketplace


A search of Facebook's Ad Library carried out by Euronews Next on August 24 revealed an array of paid adverts explicitly pushing Ivermectin as a COVID-19 treatment for humans to users in the United States.

One advert from a pharmacy chain in Louisiana claimed it was "fully stocked with Ivermectin," while another for a clinic in Arkansas said "YES I use Ivermectin to treat COVID," and claimed the drug produced positive results.

Paid adverts on Facebook make claims about Ivermectin that go against medical advice from regulators worldwide


Another advert promoting a wellness blogger's page suggested she used Ivermectin along with eating kale and blueberries to boost her immunity to disease.

The European Medicines Agency (EMA), the US Food and Drug Administration (FDA), and the World Health Organization (WHO) all say Ivermectin should only be used to treat COVID under direct medical supervision as part of controlled clinical trials.

Facebook's policy governing misleading claims in adverts on its platforms says "ads must not contain deceptive, false or misleading claims, such as those relating to the effectiveness or characteristics of a product or service".

Euronews Next asked Facebook to comment on the adverts, but the company had not responded at the time of publication.

‘Use at your own risk’


Facebook Marketplace, a service that allows users to buy and sell products, also played host to listings for Ivermectin.

One Florida-based seller offering six tubes of apple-flavoured Ivermectin paste meant for horses told Euronews Next "a lot of people" were using the drug to treat COVID-19, but claimed he "wasn't selling it for that".

"After you get it you can use it however you like," he added.

A search for "Ivermectin" in the southeastern United States brought up a number of results


When asked what the right dosage of the paste would be for a human, he said "You definitely have to use the correct dose," adding, "I have a chart but use at your own risk."

A spokesperson for the Medicines and Healthcare products Regulatory Agency (MHRA), the UK body which regulates medical products, told Euronews Next that medications must be put through robust clinical trials before being authorised for specific uses.

"A marketing authorisation for an ivermectin-containing medicine would only be issued based on robust data demonstrating a positive risk benefit for the quality, safety and efficacy of the product," they said.

No such authorisation has been obtained in the UK, US or EU.

‘For animal use only’


A search on Facebook also revealed a large number of groups devoted to Ivermectin. The largest closed group had over 25,000 members at the time Euronews Next joined.

Inside these groups were a large number of posts asking for advice on obtaining and using Ivermectin.

Some posts asked for advice on using Ivermectin. Medical regulators Euronews Next spoke to say medical advice should be sought from your doctor


Some users wanted to know how much of the drug to take, posting photos of bottles of Ivermectin clearly marked as "for animal use only".

Other posts found by Euronews Next discussed side effects of taking the drug. One user in a South Africa-based group said she was "dizzy...can't walk straight".

"My vision gets weird if I take Ivermectin a [sic] few consecutive days," said another.

The same group contained a large number of posts offering Ivermectin for sale, some of which implicitly acknowledged the drug's intended use of treating cattle and horses for parasitic worms.

One group featured a large number of posts advertising Ivermectin for sale via WhatsApp


"Moo moo juice 500ml available," one advert read, offering a price and contact number for the seller.

In February, Ivermectin maker Merck said its own analysis of studies looking at the use of the drug to treat COVID-19 found that there was "no scientific basis for a potential therapeutic effect against COVID-19 from pre-clinical studies; No meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease, and; A concerning lack of safety data in the majority of studies."

Anti-vaccine sentiment


Many of the groups Euronews Next joined contained anti-vaccine posts that spread disinformation about the COVID-19 vaccines.

The administrator of the largest Ivermectin group Euronews Next found claimed that "a question about self-medication as a layman, an anti-vaxxer post or a comment will be banned immediately". However, there was extensive evidence of anti-vaccine sentiment within the closed group.

Many users Euronews Next found in Ivermectin groups were hostile to COVID-19 vaccines


"No thank you, I won't be the government's guinea pig," responded one group member to a post encouraging users to get vaccinated. "There's an evil, hidden agenda at work," said another.

The most lurid posts in the group included wild and unsubstantiated claims that the COVID vaccines were poisonous and contained "nanobots," as well as the false claim that people who received the jabs would die within two years.

Euronews Next contacted Facebook to raise concerns about the Marketplace listings and the groups spreading disinformation about COVID vaccines and Ivermectin.

The social network did not comment at the time of publication.

Facebook under pressure


In recent weeks Facebook has come under increased pressure to tackle COVID-related disinformation on its platforms.

In July, US President Joe Biden criticised social media companies, saying the disinformation appearing on some platforms was "killing people".

Biden later clarified his comments, saying they referred to disinformation being spread by twelve specific Facebook accounts. The company has since said it has deleted the accounts.

Last year Facebook launched its COVID-19 Information Centre, which directs users to localised information about the pandemic in their country. The prompts appear next to posts about COVID or related topics, like the vaccine.

In a post responding to Biden's criticism, Facebook claimed that "more than 2 billion people have viewed authoritative information about COVID-19 and vaccines on Facebook," and that over 3 million Americans had used the company's vaccine checker to find their nearest place to get a jab.

But while the prompts Facebook displays can offer warnings about COVID disinformation to users, they do not prevent people from clicking links or sharing content.

"Every time I see that stupid Facebook fact check COVID warning I am compelled to read the article in depth," one user wrote under an article marked with a prompt that read "some unapproved COVID-19 treatments may cause serious harm".

Newsletter

Related Articles

Saudi Press
0:00
0:00
Close
Will Saudi Arabia End Up Bankrolling Israel’s Post-Ceasefire Order in Lebanon?
Saudi Arabia’s SAMAI Initiative Surpasses One-Million-Citizen Milestone in National AI Upskilling Drive
Saudi Arabia’s Specialty Coffee Market Set to Surge as Demand Soars and New Exhibition Drops in December
Saudi Arabia Moves to Open Two New Alcohol Stores for Foreigners Under Vision 2030 Reform
Saudi Arabia’s AI Ambitions Gain Momentum — but Water, Talent and Infrastructure Pose Major Hurdles
Tensions Surface in Trump-MBS Talks as Saudi Pushes Back on Israel Normalisation
Saudi Arabia Signals Major Maritime Crack-Down on Houthi Routes in Red Sea
Italy and Saudi Arabia Seal Over 20 Strategic Deals at Business Forum in Riyadh
COP30 Ends Without Fossil Fuel Phase-Out as US, Saudi Arabia and Russia Align in Obstruction Role
Saudi-Portuguese Economic Horizons Expand Through Strategic Business Council
DHL Commits $150 Million for Landmark Logistics Hub in Saudi Arabia
Saudi Aramco Weighs Disposals Amid $10 Billion-Plus Asset Sales Discussion
Trump Hosts Saudi Crown Prince for Major Defence and Investment Agreements
Families Accuse OpenAI of Enabling ‘AI-Driven Delusions’ After Multiple Suicides
Riyadh Metro Records Over One Hundred Million Journeys as Saudi Capital Accelerates Transit Era
Trump’s Grand Saudi Welcome Highlights U.S.–Riyadh Pivot as Israel Watches Warily
U.S. Set to Sell F-35 Jets to Saudi Arabia in Major Strategic Shift
Saudi Arabia Doubles Down on U.S. Partnership in Strategic Move
Saudi Arabia Charts Tech and Nuclear Leap Under Crown Prince’s U.S. Visit
Trump Elevates Saudi Arabia to Major Non-NATO Ally Amid Defense Deal
Trump Elevates Saudi Arabia to Major Non-NATO Ally as MBS Visit Yields Deepened Ties
Iran Appeals to Saudi Arabia to Mediate Restart of U.S. Nuclear Talks
Musk, Barra and Ford Join Trump in Lavish White House Dinner for Saudi Crown Prince
Lawmaker Seeks Declassification of ‘Shocking’ 2019 Call Between Trump and Saudi Crown Prince
US and Saudi Arabia Forge Strategic Defence Pact Featuring F-35 Sale and $1 Trillion Investment Pledge
Saudi Sovereign Wealth Fund Emerges as Key Contender in Warner Bros. Discovery Sale
Trump Secures Sweeping U.S.–Saudi Agreements on Jets, Technology and Massive Investment
Detroit CEOs Join White House Dinner as U.S.–Saudi Auto Deal Accelerates
Netanyahu Secures U.S. Assurance That Israel’s Qualitative Military Edge Will Remain Despite Saudi F-35 Deal
Ronaldo Joins Trump and Saudi Crown Prince’s Gala Amid U.S.–Gulf Tech and Investment Surge
U.S.–Saudi Investment Forum Sees U.S. Corporate Titans and Saudi Royalty Forge Billion-Dollar Ties
Elon Musk’s xAI to Deploy 500-Megawatt Saudi Data Centre with State-backed Partner HUMAIN
U.S. Clears Export of Advanced AI Chips to Saudi Arabia and UAE Amid Strategic Tech Partnership
xAI Selects Saudi Data-Centre as First Customer of Nvidia-Backed Humain Project
A Decade of Innovation Stagnation at Apple: The Cook Era Critique
President Trump Hosts Saudi Crown Prince Mohammed bin Salman in Washington Amid Strategic Deal Talks
Saudi Crown Prince to Press Trump for Direct U.S. Role in Ending Sudan War
Trump Hosts Saudi Crown Prince: Five Key Takeaways from the White House Meeting
Trump Firmly Defends Saudi Crown Prince Over Khashoggi Murder Amid Washington Visit
Trump Backs Saudi Crown Prince Over Khashoggi Killing Amid White House Visit
Trump Publicly Defends Saudi Crown Prince Over Khashoggi Killing During Washington Visit
President Donald Trump Hosts Saudi Crown Prince Mohammed bin Salman at White House to Seal Major Defence and Investment Deals
Saudi Arabia’s Solar Surge Signals Unlikely Shift in Global Oil Powerhouse
Saudi Crown Prince Receives Letter from Iranian President Ahead of U.S. Visit
Saudi Arabia’s Crown Prince Begins Washington Visit to Cement Long-Term U.S. Alliance
Saudi Crown Prince Meets Trump in Washington to Deepen Defence, AI and Nuclear Ties
Saudi Arabia Accelerates Global Mining Strategy to Build a New Economic Pillar
Crown Prince Mohammed bin Salman Arrives in Washington to Reset U.S.–Saudi Strategic Alliance
Saudi-Israeli Normalisation Deal Looms, But Riyadh Insists on Proceeding After Israeli Elections
Saudis Prioritise US Defence Pact and AI Deals, While Israel Normalisation Takes Back Seat
×